Thu, Mar 12, 2020
Stocks in Focus on March 12: SBI, Yes Bank, IndiGo, L&T and Biocon are the expected 5 newsmakers throughout the intraday trade.
More >
Sun, Jan 19, 2020
Biopharmaceutical company Biocon on Saturday said that its Chairperson and Managing Director Kiran Mazumdar-Shaw has been awarded the -- 'Order of Australia' -- Australia's highest civilian honour.
Fri, Oct 11, 2019
Tata Consultancy Services or TCS, Tata Steel, Biocon, Religare Enterprises and NCC are the five stocks that are expected to remain newsmakers throughout the day.
Tue, Sep 03, 2019
Certain stocks came in news after the market was closed on Friday and can have an impact on the market when it reopens today after three days break.
Tue, Aug 20, 2019
The BSE Sensex nudged 74 points down and closed at 37,328 levels while the 50-stock Nifty lost 36 points but retained the psychological 11,000 levels after closing at 11,017 levels.
Fri, Jul 26, 2019
"Robust performance by biologics and small molecules business segments fuelled the growth in the first quarter. Investments in biosimilars are delivering expected results," said Biocon Chairperson Kiran Mazumdar-Shaw in a statement later here.
Thu, Apr 25, 2019
Domestic stocks market reported sharp gains, snapping the losses of three sessions, to end in a green mark on Wednesday, April 24, 2019.
Tue, Apr 23, 2019
Domestic stocks market logged strong losses on Monday, April 22, 2019, as global crude prices spiked up and went up to its highest levels in almost six months as the US government reportedly said it won't renew waivers to allow buyers to buy Iranian crude.
Sat, Mar 02, 2019
Being a woman leader, Shaw believes Hamachar brings a diversity perspective which is integral to the company`s leadership journey.
Thu, Jul 05, 2018
Religare Finvest Limited has filed an insolvency application against Bharat Road for initiation of Corporate Insolvency Resolution process against the Company, claiming a default of about Rs 51.30 crore.
Mon, Jun 25, 2018
S&P500 mini futures fell as much as 0.5 per cent in early trade while MSCI's broadest index of Asia-Pacific shares outside Japan fell 0.2 per cent. Japan's Nikkeilost 0.4 percent.
Tue, Jun 05, 2018
Fulphila is the first FDA-approved biosimilar to Neulasta and the second biosimilar from Mylan and Biocon’s joint portfolio approved in the US Mylan anticipates launching Fulphila in the coming weeks.
Anil Singhvi suggests that traders reduce their buying positions on Nifty and BankNifty if it closes below the mark of 10,600 and 26,000 respectively.
Thu, Jan 25, 2018
The Income Tax Department today claimed to have busted a racket of extracting fraudulent tax refunds by employees of bellwether companies like IBM, Vodafone and Infosys in alleged connivance with a Chartered Accountant (CA) in Bengaluru, the IT capital of the country.
Wed, Jan 24, 2018
The company said the fall in profit was due to increase in interest and depreciation costs related to Malaysia operations and lower licensing income
Tue, Nov 14, 2017
Biocon's contract research arm Syngene International has expanded its ongoing drug discovery and development with US-based Bristol-Myers Squibb till 2026.
Fri, Jul 28, 2017
Forbes list of world's billionaires named only four Indian women. Most of whom had inherited their wealth from family businesses.
Wed, Jan 25, 2017
Biotechnology major Biocon today reported a 64.55 per cent rise in its consolidated net profit to Rs 171.3 crore for the third quarter ended December 31, led by robust growth of biologics business.
Tue, Dec 13, 2016
It said, "Syngene is in the process of assessing the extent of damage to the building and equipment and also implementating a business continuity plan to minimize impact on operations."
Fri, Aug 26, 2016
Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Top 5 stories of this afternoon: 1.Nifty slips below 8,600 as September series start
Biocon informed that EMA has accepted for review of Mylan's market authorization application (MAA) for a proposed biosimilar Trastuzumab, which is used to treat certain breast and gastric cancer.
Zee Business brings you the most important stories of the day that will help you shape your market strategies and keep you informed with the latest developments. Top 5 stories of this morning: 1. SGX Nifty flat amid weak global cues
Thu, Jul 21, 2016
Expert 'Sumit' outlook and suggestion on the stocks of Biocon. Watch this special segment and get to know more here.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
